간편결제 가능보고서 주문 후, 연도 업데이트와 커스터마이징을 위해 당사에서 연락드릴 예정입니다.
상세 사항에 따라 가격이 변동될 수 있으니 참고 바랍니다.
기본 보고서는 영문으로 작성되며, PDF,PPT,DOCX(워드) 형식으로 제공 가능합니다.
보고서 전달 후에는 환불이 불가능하오니 양해 바랍니다.
평균 납기는 2주이며, 형식과 내용에 따라 달라질 수 있습니다.
요약
모유 올리고당 (HMO) 시장. 인체 우유 올리고당 (HMO) 시장 규모는 2020 년에 7,260 만 달러로 추정되었으며 2022-2027 년 예측 기간 동안 CAGR 5.9%로 성장할 것으로 예상됩니다. 인간 우유 올리고당 산업은 장 건강에 대한 고객의 우려가 증가하고 식품 보조제 또는식이 보조제 사용 증가로 인해 큰 수요를 목격했습니다
Summary
Human Milk Oligosaccharides (HMO) Market. Human Milk Oligosaccharides (HMO) Market size was estimated at $72.6 Million in 2020, projected to grow at a CAGR of 5.9% during the forecast period 2022-2027. Human Milk Oligosaccharides industry has witnessed huge demand owing to the rising customer concerns about gut health and an increase in the use of food supplements or dietary supplements
Table of Contents
1. Human Milk Oligosaccharides Market - Overview
1.1 Definitions and Scope
2. Human Milk Oligosaccharides Market - Executive Summary
2.1 Market Revenue and Key Trends by Company
2.2 Key trends by Product
2.3 Key trends by Application
2.4 Key trends by Form
2.5 Key trends by Type
2.6 Key trends by Geography
3. Human Milk Oligosaccharides Market – Comparative Analysis
3.1 Product Benchmarking – Key Companies
3.2 Financial Analysis – Key Companies
3.3 Market Value Split - Key Companies
3.4 Patent Analysis – Key Companies
3.5 Pricing Analysis – Average Selling Price
4. Human Milk Oligosaccharides Market Forces
4.1 Market Drivers
4.2 Market Constraints/Challenges
4.3 Porters five force model
4.3.1 Bargaining power of suppliers
4.3.2 Bargaining powers of customers
4.3.3 Threat of new entrants
4.3.4 Rivalry among existing players
4.3.5 Threat of substitutes
5. Human Milk Oligosaccharides Market – Strategic Analysis
5.1 Value Chain Analysis
5.2 Opportunities Analysis
5.3 Market Life Cycle
6. Human Milk Oligosaccharides Market – By Product (Market Size –$Million/$Billion)
6.1 Lacto-N-neotetraose
6.2 Lacto-N-tetraose
6.3 2'-Fucosyllactose
6.4 3'-Fucosyllactose
6.5 3'-Sialyllactose
6.6 6'-Sialyllactose
7. Human Milk Oligosaccharides Market – By Application (Market Size –$Million/$Billion)
7.1 Food Supplements
7.2 Functional food & Beverages
7.3 Infant Formula
7.4 Others
8. Human Milk Oligosaccharides Market – By Type(Market Size –$Million/$Billion)
8.1 Acidic
8.2 Neutral
9. Human Milk Oligosaccharides Market - By Geography(Market Size –$Million/$Billion)
9.1 North America
9.1.1 U.S.
9.1.2 Mexico
9.1.3 Canada
9.2 Europe
9.2.1 U.K.
9.2.2 France
9.2.3 Germany
9.2.4 Italy
9.2.5 Spain
9.2.6 Russia
9.2.7 Rest of Europe
9.3 Asia Pacific
9.3.1 China
9.3.2 India
9.3.3 Japan
9.3.4 South Korea
9.3.5 Australia & New Zealand
9.3.6 Rest of APAC
9.4 South America
9.4.1 Brazil
9.4.2 Argentina
9.4.3 Rest of South America
9.5 Rest of the World
9.5.1 Middle East
9.5.2 Africa
10. Human Milk Oligosaccharides Market - Entropy
11. Human Milk Oligosaccharides Market Company Analysis
11.1 Company 1
11.2 Company 2
11.3 Company 3
11.4 Company 4
11.5 Company 5
11.6 Company 6
11.7 Company 7
11.8 Company 8
11.9 Company 9
11.10 Company 10
"*Financials for private companies would be provided on a best efforts basis”.
세금계산서 발행 문의
T. 070 8015 5940
보고서 주문 후, 연도 업데이트와 커스터마이징을 위해 당사에서 연락드릴 예정입니다.
상세 사항에 따라 가격이 변동될 수 있으니 참고 바랍니다.
기본 보고서는 영문으로 작성되며, PDF,PPT,DOCX(워드) 형식으로 제공 가능합니다.
보고서 전달 후에는 환불이 불가능하오니 양해 바랍니다.
평균 납기는 2주이며, 형식과 내용에 따라 달라질 수 있습니다.
요약
모유 올리고당 (HMO) 시장. 인체 우유 올리고당 (HMO) 시장 규모는 2020 년에 7,260 만 달러로 추정되었으며 2022-2027 년 예측 기간 동안 CAGR 5.9%로 성장할 것으로 예상됩니다. 인간 우유 올리고당 산업은 장 건강에 대한 고객의 우려가 증가하고 식품 보조제 또는식이 보조제 사용 증가로 인해 큰 수요를 목격했습니다
Summary
Human Milk Oligosaccharides (HMO) Market. Human Milk Oligosaccharides (HMO) Market size was estimated at $72.6 Million in 2020, projected to grow at a CAGR of 5.9% during the forecast period 2022-2027. Human Milk Oligosaccharides industry has witnessed huge demand owing to the rising customer concerns about gut health and an increase in the use of food supplements or dietary supplements
Table of Contents
1. Human Milk Oligosaccharides Market - Overview
1.1 Definitions and Scope
2. Human Milk Oligosaccharides Market - Executive Summary
2.1 Market Revenue and Key Trends by Company
2.2 Key trends by Product
2.3 Key trends by Application
2.4 Key trends by Form
2.5 Key trends by Type
2.6 Key trends by Geography
3. Human Milk Oligosaccharides Market – Comparative Analysis
3.1 Product Benchmarking – Key Companies
3.2 Financial Analysis – Key Companies
3.3 Market Value Split - Key Companies
3.4 Patent Analysis – Key Companies
3.5 Pricing Analysis – Average Selling Price
4. Human Milk Oligosaccharides Market Forces
4.1 Market Drivers
4.2 Market Constraints/Challenges
4.3 Porters five force model
4.3.1 Bargaining power of suppliers
4.3.2 Bargaining powers of customers
4.3.3 Threat of new entrants
4.3.4 Rivalry among existing players
4.3.5 Threat of substitutes
5. Human Milk Oligosaccharides Market – Strategic Analysis
5.1 Value Chain Analysis
5.2 Opportunities Analysis
5.3 Market Life Cycle
6. Human Milk Oligosaccharides Market – By Product (Market Size –$Million/$Billion)
6.1 Lacto-N-neotetraose
6.2 Lacto-N-tetraose
6.3 2'-Fucosyllactose
6.4 3'-Fucosyllactose
6.5 3'-Sialyllactose
6.6 6'-Sialyllactose
7. Human Milk Oligosaccharides Market – By Application (Market Size –$Million/$Billion)
7.1 Food Supplements
7.2 Functional food & Beverages
7.3 Infant Formula
7.4 Others
8. Human Milk Oligosaccharides Market – By Type(Market Size –$Million/$Billion)
8.1 Acidic
8.2 Neutral
9. Human Milk Oligosaccharides Market - By Geography(Market Size –$Million/$Billion)
9.1 North America
9.1.1 U.S.
9.1.2 Mexico
9.1.3 Canada
9.2 Europe
9.2.1 U.K.
9.2.2 France
9.2.3 Germany
9.2.4 Italy
9.2.5 Spain
9.2.6 Russia
9.2.7 Rest of Europe
9.3 Asia Pacific
9.3.1 China
9.3.2 India
9.3.3 Japan
9.3.4 South Korea
9.3.5 Australia & New Zealand
9.3.6 Rest of APAC
9.4 South America
9.4.1 Brazil
9.4.2 Argentina
9.4.3 Rest of South America
9.5 Rest of the World
9.5.1 Middle East
9.5.2 Africa
10. Human Milk Oligosaccharides Market - Entropy
11. Human Milk Oligosaccharides Market Company Analysis
11.1 Company 1
11.2 Company 2
11.3 Company 3
11.4 Company 4
11.5 Company 5
11.6 Company 6
11.7 Company 7
11.8 Company 8
11.9 Company 9
11.10 Company 10
"*Financials for private companies would be provided on a best efforts basis”.
